The University of Pennsylvania (Penn) Telehealth Research Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four National Cancer Institute (NCI) Telehealth Research Centers of Excellence dedicated to advancing the nation’s telehealth research agenda focused on improving cancer-related care and outcomes. With support from the White House Cancer Moonshot, Penn TRACE applies insights from communication science and behavioral economics to design and test innovative telehealth approaches to improve effectiveness and equity across the cancer care continuum, with an emphasis on advancing health equity and addressing the digital divide.
Learn more about Penn TRACE.
PC3I Faculty Roger Kim, MD, MSCE has been awarded a K08 Mentored Clinical Scientist Career Development Award from the National Cancer Institute, which provides support and mentorship to clinician scientists for research and career development activities.
PC3I is pleased to share our 2022-2023 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.
A study led by PC3I Faculty Meredith Doherty, PhD, LCSW showed that patients with cancer and survivors of cancer who engaged in administrative payment tasks were more likely to experience treatment delays or treatment nonadherence.